NYSEMKT: SER
Serina Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for SER

Based on 1 analyst offering 12 month price targets for Serina Therapeutics Inc

Min Forecast
$11.00+74.33%
Avg Forecast
$11.00+74.33%
Max Forecast
$11.00+74.33%

Should I buy or sell SER stock?

Based on 1 analyst offering ratings for Serina Therapeutics Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SER stock forecasts and price targets.

SER stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-11

1 of 1

SER vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SER$6.31$11.00+74.33%Strong Buy
GUTS$1.27$10.00+687.40%Strong Buy
PDSB$1.40$10.00+614.29%Strong Buy
VTVT$19.95$35.50+77.94%Strong Buy
RANI$1.11$9.00+710.81%Strong Buy

Serina Therapeutics Stock Forecast FAQ

Is Serina Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSEMKT: SER) stock is to Strong Buy SER stock.

Out of 1 analyst, 1 (100%) are recommending SER as a Strong Buy, 0 (0%) are recommending SER as a Buy, 0 (0%) are recommending SER as a Hold, 0 (0%) are recommending SER as a Sell, and 0 (0%) are recommending SER as a Strong Sell.

If you're new to stock investing, here's how to buy Serina Therapeutics stock.

What is SER's Price Target?

According to 1 Wall Street analyst that have issued a 1 year SER price target, the average SER price target is $11.00, with the highest SER stock price forecast at $11.00 and the lowest SER stock price forecast at $11.00.

The Wall Street analyst predicted that Serina Therapeutics's share price could reach $11.00 by Mar 11, 2026. The average Serina Therapeutics stock price prediction forecasts a potential upside of 74.33% from the current SER share price of $6.31.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.